Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue:
License and collaboration revenue	$ 267,630	$ 344,775
Total revenue	267,630	344,775
Operating expenses:
Research and development expenses	97,359	59,369
General and administrative expenses	43,947	40,505
Total operating expenses	141,306	99,874
Income from operations	126,324	244,901
Other income:
Grant income	2,091	10,181
Research and development tax credits	1,172	0
Interest income	11,361	78
Other income, net	7,788	1,304
Income before income tax expense	148,736	256,464
Income tax expense	52,084	41,943
Net income	96,652	214,521
Net income attributable to common stockholders	$ 96,652	$ 214,521
Basic net income per common share	$ 2.72	$ 6.10
Diluted net income per common share	$ 2.56	$ 5.68
Weighted-average shares used to compute net income per share, basic	35,552,025	35,181,383
Weighted-average common shares outstanding - diluted	37,766,507	37,774,790
Net income	$ 96,652	$ 214,521
Foreign currency translation adjustments	(8,478)	(1,635)
Unrealized loss related to available-for-sale debt securities	(148)
Comprehensive income	$ 88,026	$ 212,886